Read More Pharma Industry News Telix Pharmaceuticals (ASX: TLX) revenue tops $247m as pipeline spending rises Telix Pharmaceuticals revenue is accelerating, but rising R&D spending and FDA decisions will determine whether ASX: TLX can regain its premium. byVenkateshJuly 21, 2026